Largest NASDAQ Biotechnology Companies By Total Asset

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Total Asset
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Total AssetEfficiencyMarket RiskExp Return
1HROW Harrow Health
388.97 T
(0.07)
 4.13 
(0.31)
2ZYME Zymeworks Common Stock
463.09 B
(0.06)
 3.27 
(0.20)
3SNY Sanofi ADR
132.8 B
 0.18 
 1.36 
 0.25 
4CRMD CorMedix
118.85 B
(0.01)
 6.75 
(0.06)
5AZN AstraZeneca PLC ADR
104.03 B
 0.19 
 1.14 
 0.22 
6AMGN Amgen Inc
91.84 B
 0.20 
 1.49 
 0.30 
7GILD Gilead Sciences
58.99 B
 0.22 
 1.55 
 0.34 
8GMAB Genmab AS
45.81 B
(0.01)
 2.78 
(0.03)
9VTRS Viatris
41.5 B
(0.22)
 2.40 
(0.52)
10REGN Regeneron Pharmaceuticals
37.76 B
(0.07)
 2.04 
(0.13)
11BIIB Biogen Inc
28.05 B
(0.07)
 1.73 
(0.12)
12VRTX Vertex Pharmaceuticals
22.53 B
 0.24 
 1.48 
 0.35 
13BNTX BioNTech SE
22.53 B
(0.07)
 3.23 
(0.22)
14GRFS Grifols SA ADR
21.44 B
 0.00 
 2.69 
 0.01 
15RPRX Royalty Pharma Plc
18.22 B
 0.19 
 2.02 
 0.38 
16MRNA Moderna
14.14 B
(0.04)
 5.33 
(0.24)
17JAZZ Jazz Pharmaceuticals PLC
12.01 B
 0.01 
 1.81 
 0.02 
18UTHR United Therapeutics
7.36 B
(0.10)
 2.28 
(0.22)
19ROIV Roivant Sciences
7.22 B
(0.07)
 1.86 
(0.14)
20BMRN Biomarin Pharmaceutical
6.99 B
 0.09 
 1.63 
 0.15 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value. Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY